ArticleFrontiers in oncology2024

MK591 (Quiflapon), a 5-lipoxygenase inhibitor, kills pancreatic cancer cells via downregulation of protein kinase C-epsilon.

Jitender Monga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.